Pegylated Filgrastim

Member of Farmavita.Net offer  pegylated filgrastim (Peg GCSF) for out-licensing.  Finieshed dosage form is registered and registration documnetation is available in CTD Format. 

·         G-CSF is N-terminally pegylated with 20 kDa PEG molecule

·         In house pegylation, followed by purification

·         Series of tests are performed to establish Product quality, identity and efficacy comparable to Innovator like Peptide mapping, RP-HPLC, SDS page, Mass Spectroscopy, Bioassay.

·         Comparative pharmacokinetic study with the innovator in Europe

·         Product is available in liquid bulk and formulation of 6 mg / ml in PFS

Contact us for more detaills.  

Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

• In-licensing need for the Russian market (16/07/2010)
• Innovative Arthritis Medicine (09/06/2010)
• Inlicensing opportunities (06/08/2009)

• Tamsulosin SR (03/03/2008)
• Clopidogrel (30/08/2007)
• Citalopram (30/08/2007)
• Ciprofloxacine, solution (30/08/2007)
• Calcium Levo Folinate (30/08/2007)
• Bisoprolol (30/08/2007)
• Alendronate sodium (30/08/2007)
• Alprazolam (30/08/2007)
• Acetylsalicylic acid (30/08/2007)